Event Date:
April 1, 2025 - 9:00 AM CET
April 1, 2025 - 9:00 AM CET
Location:
Heidelberg, Germany
Heidelberg, Germany
BC Platforms, a proud founding member of ARTEMIs, is excited to attend the 2025 Consortium Meeting in Heidelberg, Germany, with its fellow participants.
ARTEMIs is a 4-year project launched on January 2024, to advance the management of MAFLD, Europe’s leading cause of chronic liver disease (CLD). ARTEMIs aims to control this fast-growing metabolic syndrome and its complications by leveraging advanced liver and heart Virtual Twins. The project will co-design, develop, and evaluate a clinical decision support system (CDSS) for managing MAFLD patients.
ARTEMIs is funded by the European Union under the Horizon Europe program, grant agreement N° 101136299.
Learn more about the consortium here.